Premium
Pharmacokinetics of Trastuzumab in Combination With Paclitaxel Given Every 3 Weeks in Women With HER2 Positive Metastatic Breast Cancer
Author(s) -
Ghahramani P.,
Len S. M.,
LeylandJones B.,
Gelmon K.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90662-x
Subject(s) - trastuzumab , paclitaxel , medicine , metastatic breast cancer , pharmacokinetics , oncology , breast cancer , cancer
Clinical Pharmacology & Therapeutics (2003) 73 , P83–P83; doi: